Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pain 1Neuroma 1Neuralgia 1Mastodynia 1Carpal Tunnel Syndrome 1Breast Neoplasms 1

Interventions

Bupivacaine 3Lidocaine 2Botulinum Toxins, Type A 2Ultrasonography 1Therapeutics 1Surgical Procedures, Operative 1Sodium Chloride 1Ralfinamide 1Radiofrequency Ablation 1Nerve Conduction Studies 1Musculoskeletal Manipulations 1Methylprednisolone 1Lidoderm 1Injections 1Indocyanine Green 1Electromyography 1Dry Needling 1Decompression 1Cryosurgery 1Cholecalciferol 1Bevacizumab 1Anesthetics, Local 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroma × Lidoderm × Clear all
NCT00266214 2011-06-14

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

Endo Pharmaceuticals

Phase 3 Terminated
210 enrolled

Carpal Tunnel Syndrome, Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡